Medlab Clinical Ltd

Medlab Clinical Ltd is an Australian, publicly listed biotechnology company (ASX:MDC) developing therapeutics using its proprietary, next-generation delivery platform, NanoCelle. With NanoCelle the company has launched and is investigating a broad range of prescription and non-prescription solutions for unmet patient needs across a variety of therapeutic areas including pain management, mental health, gut health, diabetes, and allergies. We fabricate remarkable pharmaceuticals that triumph against current market competition. Through our talented managerial and scientific teams, we furnish our brand warrant - to provide practitioners with innovative, evidence based products they can confidently prescribe. At Medlab Clinical Ltd, we believe that all...

Drug commercialisation,nutraceuticals,drug delivery systems,probiotics,health economics,improvement in px compliance and outcomes,biologics,early phase research,drug delevelopment,human gut microbiome,pharmaceutical ,cannabinoids,clinical trials,research,pain management ,anxiety ,vaccines,biotech ,biotechnology ,and mrna

Medlab clinical ltd operates in the Biotechnology research industry.

Medlab clinical ltd's revenue is 11m - 100m

Medlab clinical ltd has 11 - 50 employees.